855-680-0630 info@innohealthsci.com

Innovative Health Sciences is a New-York based emerging medical device company dedicated to improving and expanding upon infusion technologies.

We are at your service

Innovative Health Sciences is a New-York based emerging medical device company dedicated to improving and expanding upon infusion technologies. IHS was founded in 2019 by Andy Sealfon, engineer, inventor, and seasoned veteran to the infusion market. The company is focused on the development and commercialization of cutting-edge, innovative, products intended for use in a variety of markets, including home care, hospital, ambulatory, and military segments.

Best teams produce the highest results

IHS is comprised of a group of talented professionals that is committed to bringing the highest quality infusion products to healthcare providers and patients. IHS’ approach is patient-centric, forward-thinking, and future-oriented; the goal is to provide the highest quality of life by educating and empowering the patient to take control of their infusion.

Best healthcare through innovation

The first group of products to enter the infusion market is the Insignis™ Syringe Infusion System. This intravenous and subcutaneous syringe infusion system is comprised of a selectable rate control element, or high accuracy fixed rate flow control tubing, and a 13.5psi constant pressure syringe driver. The product line also includes subcutaneous needle sets for generic infusion applications.

We are at your service

Innovative Health Sciences is a New-York based emerging medical device company dedicated to improving and expanding upon infusion technologies. IHS was founded in 2019 by Andy Sealfon, engineer, inventor, and seasoned veteran to the infusion market. The company is focused on the development and commercialization of cutting-edge, innovative, products intended for use in a variety of markets, including home care, hospital, ambulatory, and military segments.

Best teams produce the highest results

IHS is comprised of a small group of talented professionals that is committed to bringing the highest quality infusion products to healthcare providers and patients. IHS’ approach is patient-centric, forward-thinking, and future-oriented; the goal is to provide the highest quality of life by educating and empowering the patient to take control of their infusion.

Best healthcare through innovation

The first group of products to enter the infusion market is the Insignis™ Syringe Infusion System. This intravenous and subcutaneous syringe infusion system is comprised of a selectable rate control element, or high accuracy fixed rate flow control tubing, and a 13.5psi constant pressure syringe driver. The product line also includes subcutaneous needle sets for generic infusion applications.

More about our founder

Andrew I. Sealfon
Chairman / CTO

Mr. Sealfon has been inventing and perfecting infusion device technologies for over 40 years. Mr. Sealfon’s experience combines engineering (mechanical and electronic), executive management, finance, production (medical device manufacturing), extensive FDA filing experience, including supporting the medical device regulatory process, computer and programming experience, marketing, sales, and all aspects inherent to the operation of an entrepreneurial medical device company.

As an electrical engineer and inventor, Mr. Sealfon holds numerous United States patents. Mr. Sealfon graduated from Lafayette College and continued his Graduate studies at the Polytechnic Institute in Brooklyn.

Mr. Sealfon founded RMS Medical Products (dba. Repro Med-Systems; KORU Medical Systems) in 1980. Prior to founding RMS Medical Products, he was employed by the ITT Federal Laboratories Defense Space Group as an Aerospace Engineer and Technical Staff Member, and later as a Member of the Research Staff of the Riverside Research Institute. His engineering and technical expertise prioritize patient quality of life through cutting-edge technological advances in the medical device industry.

Mr. Sealfon’s current work focuses on the design and development of a new generation of infusion devices, which will eliminate adverse reactions, increase the efficiency of the drug infusion, and ultimately improve patient quality of life.